Quick Answer
TELA Bio, Inc. reported Total Assets of $81.42 million for the year ending 2025.
- TELA Bio, Inc. showed a decrease of -6.0% in Total Assets from 2024 to 2025.
- This data is from TELA Bio, Inc.'s annual report (Form 10-K), filed with the SEC on March 25, 2026.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2019: $23.05 million | Q1 2020: $58.84 million | Q2 2020: $97.55 million | Q3 2020: $92.35 million | Q1 2021: $78.32 million | Q2 2021: $73.80 million | Q3 2021: $68.81 million | Q1 2022: $55.36 million | Q2 2022: $51.33 million | Q3 2022: $79.56 million | Q1 2023: $58.79 million | Q2 2023: $94.39 million | Q3 2023: $87.32 million | Q1 2024: $71.84 million | Q2 2024: $60.20 million | Q3 2024: $53.02 million | Q1 2025: $77.25 million | Q2 2025: $67.54 million | Q3 2025: $61.59 million.
- Over the full 8 years of available data (2018 to 2025), TELA Bio, Inc.'s Total Assets has grown by 199.0%.
- Historical annual values: Fiscal year 2025: $81.42 million | Fiscal year 2024: $86.57 million | Fiscal year 2023: $78.05 million | Fiscal year 2022: $67.86 million | Fiscal year 2021: $62.54 million | Fiscal year 2020: $86.46 million | Fiscal year 2019: $67.92 million | Fiscal year 2018: $27.23 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: